Stocks›Healthcare›NBIX

NBIX

NEUROCRINE BIOSCIENCES INC

NasdaqResearch view

Healthcare · Biological Products, (No Diagnostic Substances) · Large-cap · SEC EDGAR FY 2025-12-31

Price history

Chart: TradingView’s own feed · page prices: 1D EOD

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2025-12-31

SectorHealthcare

Market Cap$15.2B

Enterprise Value$14.5B

Income$478.6M

Sales$2.9B

Book/sh$32.00

Cash/sh$7.09

Dividend TTM—

Payout—

Employees—

IPO—

Quick Ratio3.30

Current Ratio3.39

Debt/Eq—

EPS (ttm)$4.67

EPS this Y41.9%

EPS past 3/5Y44.1%

Sales past 3/5Y24.3%

EPS Y/Y TTM41.9%

Sales Y/Y TTM21.4%

Shs Outstand101.65M

ROA10.3%

ROE14.7%

ROIC16.6%

Gross Margin—

Oper. Margin21.6%

Profit Margin16.7%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue & Earnings — fiscal year

$1.1B

2021

$1.5B

2022

$1.9B

2023

$2.4B

2024

$2.9B

2025

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$1.1B	$1.5B	$1.9B	$2.4B	$2.9B
Gross Profit	—	—	—	—	—
Operating Income	$102.5M	$249.0M	$250.9M	$570.5M	$619.1M
Net Income	$89.6M	$154.5M	$249.7M	$341.3M	$478.6M
Diluted EPS	$0.92	$1.56	$2.47	$3.29	$4.67
Operating Cash Flow	$256.5M	$339.4M	$389.9M	$595.4M	$782.7M
Free Cash Flow	$233.1M	$322.9M	$361.6M	$557.2M	$748.7M